The clot thickens

Kidney International

Volumn 70, Issue 4, 2006, Pages 620-621

  Fogo, A B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; COMPLEMENT FACTOR H; DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTERIOSCLEROSIS; BLOOD CLOT; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MIGRATION; DIABETES MELLITUS; DISEASE SEVERITY; DNA EXTRACTION; DRUG TARGETING; FAMILY HISTORY; FETUS GROWTH; GENE MUTATION; GENETIC ANALYSIS; GLOMERULOSCLEROSIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; LOW BIRTH WEIGHT; MALIGNANT HYPERTENSION; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN FUNCTION; RACE DIFFERENCE; REVIEW; RISK FACTOR; SMOKING; THROMBOPHILIA; VASCULAR FIBROSIS;

EID: 33747078716     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001721     Document Type: Note

References (10)

1. Fogo A, Breyer JA, Smith MC et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) trial. Kidney Int 1997; 51: 244-252.
2. Marcantoni C, Ma L-J, Federspiel C et al. Hypertensive nephrosclerosis in African-Americans vs Caucasians. Kidney Int 2002; 62: 172-180.
3. Meyrier A, Simon P, Montseny JJ et al. Vascular nephropathies and nephrosclerosis: epidemiology and pathophysiology. Adv Nephrol Necker Hosp 1997; 26: 207-245.
4. Kincaid-Smith P, Whitworth JA. Hypertension and the kidney. In: Kincaid-Smith P, Whitworth JA (eds). The Kidney: A Clinicopathologic Study. Blackwell: Melbourne, 1987, p 131.
5. Goforth RL, Rennke H, Sethi S. Renal vascular sclerosis is associated with inherited thrombophilias. Kidney Int 2006; 70: 743-750.
6. Fogo AB. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis 2000; 35: 179-188.
7. Eddy AA. Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 2002; 283: F209-F220.
8. Eriksson P, Kallin B, van't Hooft FM et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995; 92: 1851-1855.
9. Kimura H, Gejyo F, Suzuki Y et al. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy. Kidney Int 1998; 54: 1659-1669.
10. Abbate R, Sofi F, Gensini F et al. Thrombophilias as risk factors for disorders of pregnancy and fetal damage. Pathophysiol Haemost Thromb 2002; 32: 318-321.